Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 August 2021 | Story Leonie Bolleurs | Photo Johan Barnard
Experimental farm
The Paradys Experimental Farm donated 428 bales of animal feed to farmers who lost veld in the Fauresmith and Tierpoort districts.

“I wish I had more to give.” These are the words of Johan Barnard, Junior Lecturer and manager on the Paradys Experimental Farm of the University of the Free State (UFS) after he donated the last of 428 bales of animal feed to a farmer from the Tierpoort area this morning (4 August 2021).

After large parts of the Paradys Experimental Farm were destroyed by veld fires three years ago and 24 famers came out to help fight the fire, Barnard believes in planting a surplus of food that would enable him to share with farmers in need. Last year, he donated bales of animal feed to farmers in the Hertzogville district whose veld was destroyed.

Sharing resources

More recently – less than a month ago – veld fires destroyed thousands of hectares of land in the Tierpoort and Fauresmith districts. Barnard, who helped to put out the fires and saw the destruction, decided to make the extra animal feed available to the farmers who needed feed for their animals.

Together with research and teaching and learning, the community is one of the university’s focus areas. “As a university, we are sharing our knowledge. The destruction brought about by the veld fires has created an opportunity where the university can also share its resources,” says Barnard.

When he made the decision to help, the feed was, however, still on the fields and had to be cut, processed, and baled. But where there is a will and a community that stand together, there is a way.

The farmers in the Koppieskraal district brought their tractors and machinery to cut, rake, and bale the sorghum and grass. BKB contributed fuel to cover the running costs of the tractors and machinery.

Once the animal feed was baled, Barnard contacted Jack Armour, operations manager at Free State Agriculture, who not only spread the word to farmers that animal feed was available, but also provided fuel to deliver the bales to the farms destroyed by fires. Since last week, volunteers have come to collect the animal feed and distribute it to the farmers.

Barnard, who believes it is difficult to put a price value on the animal feed provided by the university, says to the farmers who received it, the value of these bales is priceless.

A priceless gift

Besides the thousands of hectares of pasture destroyed during the raging fires, farmers also lost a significant number of sheep and cattle. When Leon Kruger, Lecturer in the Department of Animal Science, on the experimental farm, saw the devastation caused by the fires, he posted on Facebook that he was available to assist in treating the animals.

Together with two government veterinarians and a colleague from the Glen Agricultural College, Kruger drove hundreds of kilometres to farms in the south and southwestern Free State to help farmers treat animals affected by the fires.

He says they have treated more than 800 animals, including sheep and cattle. “We treated the animals one by one, administering antibiotics and pain medication, as well as ointment to the burned areas. This difficult ordeal was, however, a baptism of fire for all of us; we are not familiar with burn wounds. A friend in Australia helped to compile criteria to classify the different degrees of burn wounds and we treated the animals accordingly.”

“Seeing the suffering of the animals was one of the most difficult ordeals I had to experience,” states Kruger, who helped several farmers save their animals during this time where they have already lost so much.


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept